Arpeggio Biosciences, Inc. is a biotech innovator specializing in advanced drug discovery solutions through the integration of transcriptomics and artificial intelligence. By leveraging cutting-edge technology and vast datasets, the company is poised to revolutionize the identification of effective treatments for complex diseases.
Company Values
Arpeggio's GRETA™ platform offers a unique combination of machine learning and comprehensive biological assays that facilitate a deeper understanding of complex cellular networks, setting the company apart in the pharmaceutical landscape.